Showing results (301-310 of 320) with videos related to
Sort By:
Pageof 32
British Journal of Cancer|August 1, 1996
Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM)P Antoniw, A P Farnsworth, A Turner, et al.Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancersE Jäger, S Gnjatic, Y Nagata, et al.International Journal of Cancer|October 3, 1999
Antigens recognized by autologous antibody in patients with renal-cell carcinomaM J Scanlan, J D Gordan, B Williamson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1987
Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding proteinN E Tolkoff-Rubin, R E Thompson, D J Piper, et al.Electrophoresis|March 1, 1997
Electrophoretic analysis of the novel antigen for the gastrointestinal-specific monoclonal antibody, A33H Ji, R L Moritz, G E Reid, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 1997
Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectorsK B Elkon, C C Liu, J G Gall, et al.International Journal of Oncology|February 10, 1998
Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude miceE C Barendswaard, A M Scott, C R Divgi, et al.Biochemical and Biophysical Research Communications|July 30, 1997
Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epitheliumG Ritter, L S Cohen, E C Nice, et al.Cancer Research|July 17, 2001
Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptorK Mishima, T G Johns, R B Luwor, et al.Proceedings of the National Academy of Sciences of the United States of America|September 27, 2000
Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I alleleS Gnjatic, Y Nagata, E Jager, et al.Pageof 32